WMG Financial Advisors’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
ECSS
ATO
WMG Financial Advisors's ABBV Position: Q2 2026 in Review
WMG Financial Advisors reduced its AbbVie (ABBV) stake by 5.4% in Q2 2026, selling an estimated $13.3K and leaving 1,076 shares worth $271K. The position accounts for 0.1% of the portfolio, ranked #78.
WMG Financial Advisors first reported a position in ABBV in Q4 2021 and has held it in 19 quarters since. The position peaked at $537K in Q1 2022. 2,121 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- WMG Financial Advisors held 1,076 shares of AbbVie worth $271K as of Q2 2026.
- WMG Financial Advisors sold 62 AbbVie shares in Q2 2026, an estimated $13.3K.
- AbbVie made up 0.1% of WMG Financial Advisors's portfolio in Q2 2026, its #78 holding.
- WMG Financial Advisors first reported a position in AbbVie in Q4 2021 and has held it in 19 quarters since.
- WMG Financial Advisors's AbbVie position peaked at $537K in Q1 2022.
- 2,121 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on WMG Financial Advisors's 13F filing for Q2 2026, filed 23 Jul 2026.